Seventeen patients with moderately active SLE participated in a double-blind, crossover study on the effect of MaxEPA, using olive oil as the control substance. During the first 3 months, 8/17 on Max EPA but only 2/17 on the control substance clinically and serologically improved (p = 0.05), but at 6 months there was no difference. The beneficial effect (if any) of MaxEPA on the disease was short-lived.

Fish Oil

Health conditions analyzed in this study

Lupus

2 supplements Moderately Positive Fish Oil Moderately Positive Fish Oil

Functions related to this study

Immunity

1 supplement Moderately Positive Fish Oil

---

Body systems related to this study

Immune System

1 supplement Fish Oil